EUVIMED · CrossrefZeitschrift
MD Conference Express
ISSN 1559-8977 · CLOCKSS Archive
Neueste Artikel
Atrial Fibrillation Management: A Shifting Paradigm
Updates on Valvular Heart Disease
AHA President Encourages Cardiologists to Help Patients Change Lifestyle Habits
Varenicline Aids Smoking Cessation
ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation
OmniHeart: Shifting Carb, Protein, and Fat Balance Lowers Heart Disease Risk
PROactive: In Prior MI Patients Pioglitazone Lowers Risks
FIELD (Fenofibrate Intervention and Event Lowering in Diabetes)
Hypertension Update
Unlocking the Secrets to a Woman's Heart: New Information Narrows the Gender Gap in Cardiac Care
The AURICULA Project: New Warfarin Dosing Software Unveiled
Medically Induced Mild Hypothermia Improves Chances of Survival for Heart Attack Patients
Metabolic Syndrome Update
IDEAL--Lowering CHD Risk with High-Dose Statins
Heart Failure Update
Challenges in ACS
Early Initiation of Eptifibatide for Heart-Attack Patients in Emergency Department Achieved Superior Coronary Artery Blood Flow
Lipid Management Update
PCI Guideline Update
Inhaled Insulin: Safety and Appropriate Uses
GLP-1 -- The New Darling of Diabetes Treatment
Three Common Genetic Variants Predict Type 2 Diabetes
Intensive Treatment of Diabetes Does Not Impair Cognitive Functioning
Hyperglycemia and Mortality in over 200,000 Critically III Patients
IL-1 Receptor Antagonist Therapy in Type 2 Diabetes
Look AHEAD Trial in Type 2 Diabetes: Results from Year 1
New Therapies: Vildagliptin
New Treatments: Sitagliptin
New Treatments: Liraglutide
Insulin Update
EUVIMED